Wall Street analyst estimates for Creative Medical Technology Holdings, Inc. (CELZ): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 0.35 |
| EV / EBITDA | 0.96 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | $4800 | $124400 | $165500 | $164500 | $87754 | $88600 | $9000 | $11000 | $6000 |
| Cost of Revenue | $766072 | $8000 | $70375 | $45499 | $50596 | $47949 | $28491 | $3600 | $4400 | $2194 |
| Gross Profit | -$766072 | -$3200 | $54025 | $120001 | $113904 | $39805 | $60109 | $5400 | $6600 | $3806 |
| Research & Development | $85334 | $260085 | $96621 | 0 | 0 | $109180 | $6.3M | $2.0M | $2.4M | $2.3M |
| Selling, General & Admin | $664984 | $898526 | $1.1M | $1.2M | $1.2M | $3.0M | $3.9M | $3.6M | $3.2M | $3.8M |
| Operating Expenses | $759674 | $1.2M | $1.2M | $1.3M | $1.2M | $3.2M | $10.3M | $5.6M | $5.8M | $6.1M |
| Operating Income | -$766072 | -$1.2M | -$1.1M | -$1.1M | -$1.1M | -$3.1M | -$10.2M | -$5.6M | -$5.7M | -$6.1M |
| EBITDA | -$750318 | -$1.2M | -$1.1M | -$6.6M | -$35.0M | $23.6M | -$10.1M | -$5.2M | -$5.4M | -$6.0M |
| Interest Expense | $6398 | $377587 | $1.4M | $1.9M | $1.2M | $4.3M | 0 | 0 | 0 | 0 |
| Pre-tax Income | -$766072 | -$2.7M | -$13.7M | -$8.5M | -$36.3M | $19.2M | -$10.1M | -$5.3M | -$5.5M | -$6.0M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$766072 | -$2.7M | -$13.7M | -$8.5M | -$36.3M | $19.2M | -$10.1M | -$5.3M | -$5.5M | -$6.0M |
| EPS | $-5471.94 | $-17379.79 | $-11351.33 | $-5017.67 | $-626.88 | $73.75 | $-9.28 | $-3.76 | $-3.71 | $-2.52 |
| EPS (Diluted) | $-5471.94 | $-17379.79 | $-11351.33 | $-5017.67 | $-626.88 | $56.10 | $-9.28 | $-3.76 | $-3.71 | $-2.52 |
| Shares Outstanding (Diluted) | $140 | $153 | $1203 | $2068 | $57946 | $324861 | $1.1M | $1.4M | $1.5M | $2.4M |
Price
| Price | $0.82 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ACXP · ADIL · ADXN · ALZN · APRE · BCDA · CDIO
Explore sector: Healthcare · Biotechnology
More sections of CELZ: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks